Back

Ajmaline testing in Brugada Syndrome: a comparative analysis of diagnostic protocols and clinical outcomes across two hospital centers

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in arrhythmias and device therapy 2 Clinical HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Catia Oliveira

Sao Joao Hospital, Porto (Portugal)

5 More presentations in this session

Presentation thumbnail
Gender difference in life threatening arrhythmias in patients with non-ischaemic cardiomyopathy
Doctor I. Chung (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Gender difference in clinical outcomes in patients with hypertrophic cardiomyopathy
Doctor I. Chung (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Predictors of implantable cardio-defibrillator activation in patients with hypertrophic cardiomyopathy at primary prevention of sudden cardiac death
Doctor M. Marques Antunes (Lisboa, PT)
Abstract Slides Video
Presentation thumbnail
Unraveling the story of hundreds of syncopes and pre-syncopes
Doctor M. Castro (Guimaraes, PT)
Abstract Slides Video
Presentation thumbnail
The risk of life-threatening forecast scale
Assistant Professor N. Kulaiets (Ivano-Frankivsk, UA)
Abstract Slides

Access the full session

Session thumbnail
ePosters in arrhythmias and device therapy 2

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Non-pharmacological early detection of concealed Brugada syndrome via basal ECG analysis
thumbnail
Congress Presentation
The diagnostic efficacy of the ajmaline challenge in SCN5A positive Brugada syndrome patients
thumbnail
Congress Presentation
Baseline intervals on electrocardiogram as a screening tool for diagnosing brugada syndrome in family members

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources